Clinical trials
Obese clinical trials
Below are recruiting obese clinical trials, each written for real people, not researchers. We’re tracking 1,500 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07229508Recruiting
Weight gain study for children from BIPOC or low-income families
This study looks at how children gain weight over time, especially in families of color or with low income. It helps understand why some kids struggle with weight and what can be done to help.
Buffalo, New YorkAges 8–11 - NCT07236788Recruiting
Iron infusion to prevent anemia and improve life in obese patients
This trial tests whether giving an intravenous iron supplement (ferric derisomaltose) can help prevent anemia and improve quality of life in obese patients who have low iron stores. It aims to see if this treatment can boost energy and reduce fatigue.
BeijingAges 18–65 - NCT07239973RecruitingPhase 1
Study of BGM0504 Tablets for overweight or obese adults
This trial tests a new tablet, BGM0504, in healthy adults who are overweight or obese but do not have diabetes. It aims to see how the medicine works and if it is safe for this group.
Kunming, YunnanAges 18–55 - NCT07242534RecruitingPhase 4
Semaglutide for better embryos in IVF for women with overweight or obesity
This trial tests whether semaglutide, a medication used for weight management, can improve the quality of embryos in women who are overweight or have obesity and are doing IVF. It aims to see if taking semaglutide before the IVF process helps make healthier embryos that can be frozen for later use.
Sabadell, BarcelonaAges 18–38 - NCT07245771RecruitingPhase 1/Phase 2
Weight loss study testing a new drug alone or with tirzepatide
This trial tests an experimental drug called RN3161 to see if it helps with weight loss in people with overweight or obesity. It can be taken alone or with another weight-loss medication (tirzepatide).
Melbourne, VictoriaAges 18–65 - NCT07247084RecruitingPhase 4
Tirzepatide for weight loss in adults with obesity
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
AltrinchamAges 18 years+ - NCT07037459RecruitingPhase 3
A study of a new drug for heart failure with obesity
This trial tests a medication called maridebart cafraglutide for people with heart failure (where the heart doesn't pump as well as it should) and obesity. The goal is to see if it can help improve symptoms and outcomes.
Birmingham, AlabamaAges 18–99 - NCT07261475RecruitingEarly Phase 1
Saffron petal extract for weight and blood sugar
This study tests a water extract from saffron flower petals to see if it helps with weight loss or blood sugar control in people with obesity or prediabetes. It's an early-phase trial, so it's looking at safety and how the body handles the extract.
IzolaAges 40–65 - NCT07279194RecruitingPhase 3
Study of HDM1005 for weight loss in Chinese adults without diabetes
This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.
ShanghaiAges 18 years+ - NCT07280936RecruitingPhase 1
Study of SHR-2906 in healthy people and those with obesity
This trial tests a new injection called SHR-2906, first in healthy people to check safety, then in people with obesity to see how well it works. It may help with weight management.
Hangzhou, ZhejiangAges 18–55 - NCT07282600RecruitingPhase 3
Study of eloralintide for type 2 diabetes and weight
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
Birmingham, AlabamaAges 18 years+ - NCT07292389Recruiting
Weight loss study testing feedback messages
This study tests whether different types of feedback messages help with weight loss. You'll use a smartphone app, a Fitbit, and a scale to track your progress over 17 weeks.
Charlottesville, VirginiaAges 18 years+ - NCT07294235RecruitingPhase 1
Study of BGM1812 injection for healthy and overweight or obese participants
This trial tests an investigational drug called BGM1812 given as an injection. It is for healthy Chinese adults who are either at a normal weight or are overweight/obese but not diabetic. The study will see how the drug works in the body and check for side effects.
Kunming, YunnanAges 18–55 - NCT07307417Recruiting
Breathing muscle training for obesity
This trial tests if training your breathing muscles can improve respiratory function in people with obesity. It aims to help those with a BMI of 30 or higher.
Wroclaw, Dolny ŚląskAges 30–60 - NCT07315282Recruiting
Iron supplements for overweight women: effects on blood sugar
This study tests whether oral iron supplements can improve how the body uses insulin and manages blood sugar in overweight or obese women with low iron stores.
BeirutAges 18–45 - NCT07315659Recruiting
Time-restricted eating for weight loss maintenance in obesity
This study tests whether eating only during a set window of hours each day can help people with obesity keep weight off after losing it. You would follow a specific meal schedule and get all your food provided for a period.
Granada, GranadaAges 18–70 - NCT07326111RecruitingPhase 4
Tirzepatide for PCOS and weight in women
This study tests if tirzepatide (a once-weekly injection) can improve periods and metabolic health in women with PCOS who are overweight. If you have PCOS, irregular cycles, and a BMI of 27 or higher, you might qualify.
BochumAges 18–45 - NCT07332273RecruitingPhase 3
Levothyroxine for weight loss in obesity
This trial tests whether adding levothyroxine (a thyroid hormone) to a low-calorie diet helps people with obesity lose more weight. It is for adults aged 25-60 with a BMI of 30-39.9 who have either mild underactive thyroid or normal thyroid but higher thyroid hormone levels in the normal range.
CadizAges 25–60 - NCT07364175Recruiting
Weight loss drug study for young adults with high blood pressure
This trial tests if the weight loss medication tirzepatide can help young adults (18–40) with obesity and high blood pressure lower their blood pressure. It compares standard care to weight loss with tirzepatide.
Cambridge, CambridgeshireAges 18–40 - NCT07368842Recruiting
Scalp hair study in severe obesity
This study looks at chemicals in scalp hair from people with severe obesity to learn more about the condition. Participants must be planning to have weight-loss surgery.
SingaporeAges 21–70 - NCT07372157Recruiting
Balance exercises for people with overweight or obesity
This trial tests if neuromuscular balance exercises can help people who are overweight or obese. It aims to improve movement and stability.
Istanbul, IstanbulAges 18–65 - NCT07373834Recruiting
Tirzepatide and muscle health in women with obesity
This study tests whether tirzepatide, a medication for weight management, affects muscle health in women with obesity. It may help if you are looking for a treatment that preserves muscle while losing weight.
LjubljanaAges 18–50 - NCT07387094RecruitingPhase 3
A study of XW003 for obesity with sleep apnea (no CPAP)
This trial tests an investigational weekly injection called XW003 for weight loss in people who have obesity and moderate-to-severe sleep apnea but do not use a CPAP machine. It aims to see if the drug can help with weight loss and improve sleep apnea without the need for a breathing machine.
Beijing, Beijing MunicipalityAges 18–75 - NCT07392905Recruiting
How the brain and body respond to food in obesity
This study looks at how your brain and body respond to food based on your weight. You'll eat a standard meal and have brain scans (MRI) to see how your brain reacts.
Nanjing, JiangsuAges 18–40
Hear when a new Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obese?
- Yes. Clin2 currently lists 1,500 recruiting obese studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obese trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obese trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.